15 results · 40ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

BIOMEDICS 55 (OCUFILCON D) UV BLOCKING SOFT (HYDROPHILIC) CONTACT LENS

FDA 510(k)
FDA Class 2 ·Ophthalmic

INRATIO2 PT/INR TEST STRIPS

FDA Adverse Event
Malfunction ·ALERE SAN DIEGO, INC.·Product code GJS·April 13, 2016

Dental Pain Eraser

FDA 510(k)
FDA Unclassified ·Unknown

LENSX 550 LASER SYSTEM

FDA 510(k)
FDA Class 2 ·Ophthalmic

SUPRACONDYLAR NAIL T2 SCN 10 X 200 MM

FDA Adverse Event
Injury ·STRYKER OSTEOSYNTHESIS ¿ KIEL·Product code HSB·July 17, 2012

UNKNOWN BROACH

FDA Adverse Event
Injury ·DEPUY ORTHOPAEDICS INC US·Product code LPH·January 31, 2013

PK DISSECTING FORCEPSINSTRUMENT

FDA Adverse Event
Malfunction ·INTUITIVE SURGICAL,INC.·Product code NAY·February 28, 2013

PRECISION XTRA

FDA Adverse Event
Malfunction ·Product code NBW·February 9, 2011

840 VENTILATOR

FDA Adverse Event
Malfunction ·COVIDIEN, FORMERLY NELLCOR PURITAN BENNETT IRELAND·Product code CBK·July 2, 2014

PINNACLE MTL INS NEUT36IDX50OD

FDA Adverse Event
Injury ·DEPUY ORTHOPAEDICS INC US·Product code KWA·October 15, 2012

PINNACLE MTL INS NEUT36IDX52OD

FDA Adverse Event
Injury ·DEPUY ORTHOPAEDICS INC US·Product code KWA·October 15, 2012

ASPHERE M SPEC 12/14 36 +8.5

FDA Adverse Event
Injury ·DEPUY ORTHOPAEDICS INC US·Product code KWA·October 15, 2012

ASPHERE M SPEC 12/14 36 +8.5

FDA Adverse Event
Injury ·DEPUY ORTHOPAEDICS INC US·Product code KWA·October 15, 2012

Exactech Equinoxe REVERSE SHOULDER,42mm Constrained Humeral Liner, a) +0mm, Item number 320-42-10, b) +2.5mm, Item Number 320-42-13; Shoulder Arthroplasty

FDA Enforcement
Class II ·Ongoing·Exactech, Inc.·April 10, 2024

Assurity Model Numbers: PM1240, PM2240; Assurity + Model Number: PM2260; Accent Model Numbers: PM1210, PM2210, PM1222, PM2212; Accent MRI Model Numbers: PM1224, PM2218, PM2224 Implantation of a single-chamber pulse generator, dual-chamber pulse generator, or CRT-P is indicated in one or more of the following permanent conditions: Syncope, Presyncope, Fatigue, Disorientation, Or any combination of those symptoms. Implantation of a CRT-P is indicated for: Maintaining synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic atrial fibrillation and have NYHA Class II or III heart failure. The reduction of the symptoms of moderate to severe heart failure (NYHA Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy, and have a left ventricular ejection fraction d35% and a prolonged QRS duration

FDA Enforcement
Class II ·Terminated·St Jude Medical Inc.·October 25, 2017